Found 18 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
Study of an investigatonal medication for Type 1 Diabetes in children
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with moderate to severe Crohn's Disease. The purpose of this study is to evaluate how well different doses of an investigational medication work compared to a placebo in adults with moderate to severe Crohn's Disease.The study focuses …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates ulcerative colitis. It focuses on evaluating the effects of an investigational medication on patients with this condition.The study will assess the safety and effectiveness of the investigational medication. It will look at how well patients tolerate the treatment.Who can participate: Participants aged 18 to 75 years with …
18 years or above
All genders
Phase 3
Interventional
This study investigates warm autoimmune hemolytic anemia. It compares the effects of an investigational medication with a placebo.The study evaluates the safety and effectiveness of the investigational medication. It focuses on how well the medication works and how the body processes it.Who can participate: Participants must be 18 years or …
40 years - 85 years
All genders
Phase 4
Interventional
This study investigates the effects of an investigational medication on airway inflammation, resistance, and remodeling, including mucus plugging, in individuals with Chronic Obstructive Pulmonary Disease (COPD).The study evaluates how these factors relate to lung function, exacerbations, and quality of life.Who can participate: Participants aged 40 to 85 years with a …
1 year - 11 years
Male
Phase 3
Interventional
This study investigates hemophilia A and B in young boys. The purpose of this study is to evaluate the efficacy and safety of an investigational medication given to male participants aged 1 to less than 12 years who have severe hemophilia A or B.The study focuses on understanding how well …
18 years or above
All genders
Phase 2
Interventional
This study investigates moderate to severe hidradenitis suppurativa. The purpose of this study is to evaluate different doses of an investigational medication.The study focuses on assessing the safety and effectiveness of the investigational medication. It evaluates how well the medication works and how safe it is for participants.Who can participate: …
12 years or above
All genders
Phase 3
Interventional
This study investigates moderate-to-severe AD. The purpose of this study is to evaluate the effects of an investigational medication given as a subcutaneous injection on patients who have previously not responded well to certain treatments.The study focuses on assessing the safety and effectiveness of the investigational medication compared to a …
16 years - 75 years
All genders
Phase 2
Interventional
This study investigates primary focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD).It evaluates the safety and effectiveness of investigational medications by measuring changes in proteinuria and their impact on nephrotic syndrome remission rates.Who can participate: Participants aged 16 to 75 years with focal segmental glomerulosclerosis or minimal change disease …
1 - 10 of 18